AzTrials
AzTrials

IntubationNCT00814775

Comparison Between the Fastrach and CTrach Laryngeal Mask Airway

A study testing Fastrach Laryngeal Mask and CTrach Laryngeal Mask in people with Intubation, run by The Cleveland Clinic at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effectiveness of the Fastrach and the CTrach Laryngeal mask airway to achieve placement of a breathing tube in the windpipe of patients where this may be difficult. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intubation
What is being tested?
Fastrach Laryngeal Mask and CTrach Laryngeal Mask
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteUnited States
Study dates
Aug 2008to Jun 2010
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with an ASA score of 1-3.
  • Scheduled for elective surgical procedure
  • Age 18 and above
  • Patients with Mallampati airway classification scores III and IV

Who cannot join

  • Current pregnancy
  • Patients undergoing brain aneurysm clipping brain arteriovenous malformation surgery or vascular surgery procedures
  • Patients with obstructive sleep apnea or with a history of difficult ventilation
  • Mouth opening less than 3 cm.
  • Patients with indication for awake fiberoptic intubation or with a history of difficult intubation
  • Patients with cancer of the neck or the upper airway
Show all 9Show fewer
  • Emergent surgery, patients requiring rapid sequence induction
  • Patients with severe gastroesophageal reflux
  • Patients with severe cardiac, pulmonary, hepatic or renal co-morbidities. 10. Patients unable to consent their participation in the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cleveland Clinic

    Cleveland, Ohio, 44195

Other trials in United States

About this study

Official title: Comparison Between the Fastrach and CTrach Laryngeal Mask Airway for Intubation of Patients With a Mallampati Score 3 or 4

The purpose of this study is to determine the effectiveness of the Fastrach and the CTrach Laryngeal mask airway to achieve placement of a breathing tube in the windpipe of patients where this may be difficult.

Read the detailed description

Participant will be randomly assigned to receive one of 2 conventional airway devices - the Fastrach Laryngeal Mask Airway or the CTrach Laryngeal Mask Airway. This study will compare the time required for successful intubation between the two devices.

Postoperative visit will be performed to assess the participant's clinical condition and to receive participant's feed back.

Conditions
Intubation
Being tested
Fastrach Laryngeal Mask, CTrach Laryngeal Mask
Keywords
Laryngeal mask, Difficult intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fastrach Laryngeal MaskDevice

    Intubation of difficult airway using Fastrach Laryngeal Mask

  • CTrach Laryngeal MaskDevice

    CTrach Laryngeal Mask intubation

Study groups in NCT00814775
Study groupRoleWhat they receive
Group 1Active comparatorFastrach Laryngeal Mask Airway intubation
Receives: Device: Fastrach Laryngeal Mask
Group 2Active comparatorIntubation of difficult airway using CTrach Laryngeal Mask
Receives: Device: CTrach Laryngeal Mask

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To Compare the Time Required for Successful Intubation Between the Fastrach and CTrach LMA Devices in Patients With a Mallampati Score III and IV Without Use of Fiberoptic Bronchoscopy

    Measured: from start of intubation to successfully intubated

  2. To Compare the Time Required for Successful Intubation Between the Fastrach and CTrach LMA Devices in Patients With a Mallampati Score III and IV Use of Fiberoptic Bronchoscopy

    Measured: 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Dec 2008 (estimated)
  2. Study startAug 2008
  3. Primary completionJun 2010
  4. Study completionJun 2010

Why it stopped: recruitment challenges, device no longer available

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00814775
Sponsor's protocol ID
08-358
Status last verified
Aug 2016
First submitted
23 Dec 2008
Last updated
17 Oct 2016
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Fastrach Laryngeal Mask and CTrach Laryngeal Mask in people with Intubation, run by The Cleveland Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 17 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 Oct 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To Compare the Time Required for Successful Intubation Between the Fastrach and CTrach LMA Devices in Patients With a Mallampati Score III and IV Without Use of Fiberoptic Bronchoscopy (time frame: from start of intubation to successfully intubated). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in